Kidney disease commonly referred to as kidney disease or kidney disease, mainly manifested as abnormal urine volume, urination abnormalities, lumbago.Kidney disease drugs include blood pressure drugs, anti-hyperlipidemia drugs, erythropoietics (ESA), diuretics and so on.
This report contains market size and forecasts of Renal Diseases Drug in Global, including the following market information:
Global Renal Diseases Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Renal Diseases Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Chronic Kidney Disease (CKD) Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Renal Diseases Drug include Pfizer, Amgen, Roche, GlaxoSmithKline (GSK), Allergan, AbbVie, Kissei Pharmaceutical, AstraZeneca and FibroGen, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Renal Diseases Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Renal Diseases Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Renal Diseases Drug Market Segment Percentages, by Type, 2021 (%)
Chronic Kidney Disease (CKD) Drugs
End-Stage Kidney Disease (ESRD) Drugs
Global Renal Diseases Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Renal Diseases Drug Market Segment Percentages, by Application, 2021 (%)
Hospitals
Specialty Clinics
Other
Global Renal Diseases Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Renal Diseases Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Renal Diseases Drug revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Renal Diseases Drug revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Amgen
Roche
GlaxoSmithKline (GSK)
Allergan
AbbVie
Kissei Pharmaceutical
AstraZeneca
FibroGen
Sanofi
Teva Pharmaceutical Industries
Johnson & Johnson
Keryx Biopharmaceuticals